Translational Development at Celgene
Translational Development is part of the Global Research and Early Development organization in Celgene and leads early stage clinical, pharmacological and translational research and development activities for the pipeline and supports late stage portfolio for regulatory, translational development and life cycle management. Translational Development is in the process of organizing a late translational group to support multiple disease areas of interest including Myeloma, Lymphoma, CLL and other hematological malignancies. This group will integrate scientific and business insights of multiple functions and lead the development of translational strategies at the franchise level and implement them in project teams to maximize the potential of Celgene drugs.
Reporting to the Executive Director Translational Development, the principal scientist will be part of the late translational group based in Summit NJ and will be the lead translational scientist/strategist in the Lymphoma/CLL area. Key responsibilities of this role is to act as the translational representative in Project teams for Lymphoma/CLL programs and assume primary responsibilities for supporting projects and key strategic areas.
Requirements & Education:
Not ready to apply?Join Our Talent Network
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients.